Literature DB >> 1702831

Substance P-induced release of prostaglandins from astrocytes: regional specialisation and correlation with phosphoinositol metabolism.

D R Marriott1, G P Wilkin, J N Wood.   

Abstract

Addition of substance P (SP) to astrocytes cultured from rat neonatal spinal cord evoked a time- and concentration-dependent increase in the accumulation of phosphoinositol and the release of prostaglandin (PG) D2 and PGE2. Both basal and stimulated releases were reduced to similar levels by indomethacin. In contrast, astrocytes cultured from cerebral cortex and cerebellum showed no SP-stimulated increase in phosphoinositol accumulation or release of PGs. Release of PGD2 and PGE2 was, however, stimulated by the calcium ionophore A23187, and both phosphoinositol accumulation and PG release were stimulated from cortical astrocytes incubated in the presence of serum. The results from this study suggest that SP-stimulated phosphoinositol accumulation and release of PGs from cultured rat neonatal astrocytes are regionally specialised in favour of cells derived from spinal cord.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1702831     DOI: 10.1111/j.1471-4159.1991.tb02590.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  14 in total

1.  Norman Cousins Lecture. Glia as the "bad guys": implications for improving clinical pain control and the clinical utility of opioids.

Authors:  Linda R Watkins; Mark R Hutchinson; Annemarie Ledeboer; Julie Wieseler-Frank; Erin D Milligan; Steven F Maier
Journal:  Brain Behav Immun       Date:  2006-12-18       Impact factor: 7.217

2.  Substance P-induced cyclooxygenase-2 expression in human umbilical vein endothelial cells.

Authors:  Margherita Gallicchio; Arianna Carolina Rosa; Elisa Benetti; Massimo Collino; Chiara Dianzani; Roberto Fantozzi
Journal:  Br J Pharmacol       Date:  2006-03       Impact factor: 8.739

3.  Intrathecal HIV-1 envelope glycoprotein gp120 induces enhanced pain states mediated by spinal cord proinflammatory cytokines.

Authors:  E D Milligan; K A O'Connor; K T Nguyen; C B Armstrong; C Twining; R P Gaykema; A Holguin; D Martin; S F Maier; L R Watkins
Journal:  J Neurosci       Date:  2001-04-15       Impact factor: 6.167

4.  In vitro prostanoid release from spinal cord following peripheral inflammation: effects of substance P, NMDA and capsaicin.

Authors:  D M Dirig; T L Yaksh
Journal:  Br J Pharmacol       Date:  1999-03       Impact factor: 8.739

5.  Neurokinin-1 receptor desensitization attenuates cutaneous active vasodilatation in humans.

Authors:  Brett J Wong; Christopher T Minson
Journal:  J Physiol       Date:  2006-10-05       Impact factor: 5.182

Review 6.  Role of spinal cord glia in the central processing of peripheral pain perception.

Authors:  S Bradesi
Journal:  Neurogastroenterol Motil       Date:  2010-03-16       Impact factor: 3.598

7.  The role of spinal neuropeptides and prostaglandins in opioid physical dependence.

Authors:  Tuan Trang; Maaja Sutak; Remi Quirion; Khem Jhamandas
Journal:  Br J Pharmacol       Date:  2002-05       Impact factor: 8.739

8.  Endogenous peptidergic modulation of perisynaptic Schwann cells at the frog neuromuscular junction.

Authors:  M J Bourque; R Robitaille
Journal:  J Physiol       Date:  1998-10-01       Impact factor: 5.182

9.  The effect of morphine on formalin-evoked behaviour and spinal release of excitatory amino acids and prostaglandin E2 using microdialysis in conscious rats.

Authors:  A B Malmberg; T L Yaksh
Journal:  Br J Pharmacol       Date:  1995-03       Impact factor: 8.739

10.  Microglial activation in different models of peripheral nerve injury of the rat.

Authors:  Stanislava Jergová; Dása Cízková
Journal:  J Mol Histol       Date:  2007-05-15       Impact factor: 3.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.